-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Mereo BioPharma Group plc quarterly and annual Revenues in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
- Mereo BioPharma Group plc Revenues for the quarter ending 30 Sep 2025 was $0.
- Mereo BioPharma Group plc annual Revenues for 2024 was $0, a 100% decline from 2023.
- Mereo BioPharma Group plc annual Revenues for 2023 was $10,000,000.